2014 NextGen Genomics & Bioinformatics
Your privacy is important to www.sgrfconferences.com. sgrfconferences recognizes that when you choose to provide us with information about yourself, you trust us to act in a responsible manner. This information helps us improve your book-browsing or purchasing experience with better content, services and opportunities. This policy tells you about the information gathering and dissemination that we conduct. As sgrfconferences continues to grow, this policy may change, so please check back periodically for updates.
1.Collection of Information:
2. Use of information:
The Website shall use the information to analyse the same to provide such services requested by the user. The profile/general information given by users shall be used to keep track of viewing preferences of the user.
3. Change of User Information:
4. Protection of user information:
We have the following security procedures and software in place to ensure that your personal information is kept confidential:
sgrfconferences may disclose the personally identifiable information only in the following circumstances:
TERMS AND CONDITIONS FOR USE OF WEBSITE
Refund and Cancellation Policy:
SciGenom conferences reserves the right to cancel/refund a registration. Please send your cancellation request to email@example.com
Though gene expression studies have made considerable progress in understanding the molecular changes in a given disease or condition, these changes can be easily monitored at the protein level using Proteomics. Proteomics offers the technology to identify the changes occurring in the proteome and understand what such changes translate into, in understanding the disease. Mass spectrometry based largescale proteomic studiesdoes the same at two stages- the discovery stage, where a fingerprint of the protein profile with respect to a particular disease condition is obtained and the quantitation stage, where the degree of protein expression is absolutely quantified for its validation as a potential biomarker. Proteomic studies on clinical specimens as tissue biopsies or body fluids such as tears, blood, saliva, urine etc increase the relevance of the study to the actual clinical set-up and aid in rapid identification of biomarkers for the disease. Using NextGen proteomics technologies as data independent acquisition, the current workshop aims to provide an insight into identification and validation of proteins as biomarkers which can act as prognostic/diagnostic biomarkers or potential drug targets for therapy.
Workshop Venue: Narayana Nethralaya, INDIA
Date: 14 Nov 2014 Time: 09:00 AM - 05:00 PM
Registration is limited to 15 participants for the hands on session.
Dr. Arkasubhra Ghosh
Molecular Signalling and Gene Therapy,
Director, GROW laboratory (Genes, repair and regeneration at ophthalmic workstation)
Narayana Nethralaya Foundation,
3rd Floor, Narayana Nethralaya, Narayana Health City,
# 258/A, Bommasandra, Hosur Road, Bangalore, INDIA - 560 099.